Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Silver

Showing results (21-30 of 232) with videos related to

Pageof 24
Sort By:
Expert Review of Hematology|May 22, 2015
Interferon in polycythemia vera and related neoplasms. Can it become the treatment of choice without a randomized trial?Hans Carl Hasselbalch, Richard T Silver
Leukemia|April 8, 2026
A paradigm shift in the treatment of patients with polycythemia vera. The initial early use of recombinant interferon-alphaRichard T Silver, Hans Carl Hasselbalch
Expert Review of Hematology|April 4, 2023
Polycythemia vera: aspects of its current diagnosis and initial treatmentRichard T Silver, Ghaith Abu-Zeinah
Medical Journal (Fort Sam Houston, Tex.)|April 12, 2023
A Review of Intermittent Fasting as a Treatment for Type 2 Diabetes MellitusDerek T Silver, Timothy B Pekari
Hematology (Amsterdam, Netherlands)|February 23, 2016
Optimal therapy for polycythemia vera and essential thrombocythemia: Preferred use of interferon therapy based on phase 2 trialsRichard T Silver, Hans Carl Hasselbalch
Archives of Internal Medicine|January 1, 1977
Value of biopsy in diagnosis of primary lymphosarcoma of marrowM Pasmantier, M Coleman, R T Silver
Immunological Reviews|August 22, 2001
Specificity and function of activating Ly-49 receptorsK P Kane, E T Silver, B Hazes
BMJ (Clinical Research Ed.)|January 13, 1996
Vocational training for general practice in inner London. Is there a dearth? And if so what's to be done?T Harris, T Silver, E Rink, et al.
American Family Physician|January 1, 1975
Diagnosis of plasma cell myelomaM W Pasmantier, M Coleman, R T Silver
Expert Review of Hematology|November 12, 2019
Myelofibrosis: best practices, controversies and 2019 updateNicole M Cruz, Usama Gergis, Richard T Silver
Pageof 24

Showing results (21-30 of 232) with videos related to

Sort By:
Pageof 24
Expert Review of Hematology|May 22, 2015
Interferon in polycythemia vera and related neoplasms. Can it become the treatment of choice without a randomized trial?Hans Carl Hasselbalch, Richard T Silver
Leukemia|April 8, 2026
A paradigm shift in the treatment of patients with polycythemia vera. The initial early use of recombinant interferon-alphaRichard T Silver, Hans Carl Hasselbalch
Expert Review of Hematology|April 4, 2023
Polycythemia vera: aspects of its current diagnosis and initial treatmentRichard T Silver, Ghaith Abu-Zeinah
Medical Journal (Fort Sam Houston, Tex.)|April 12, 2023
A Review of Intermittent Fasting as a Treatment for Type 2 Diabetes MellitusDerek T Silver, Timothy B Pekari
Hematology (Amsterdam, Netherlands)|February 23, 2016
Optimal therapy for polycythemia vera and essential thrombocythemia: Preferred use of interferon therapy based on phase 2 trialsRichard T Silver, Hans Carl Hasselbalch
Archives of Internal Medicine|January 1, 1977
Value of biopsy in diagnosis of primary lymphosarcoma of marrowM Pasmantier, M Coleman, R T Silver
Immunological Reviews|August 22, 2001
Specificity and function of activating Ly-49 receptorsK P Kane, E T Silver, B Hazes
BMJ (Clinical Research Ed.)|January 13, 1996
Vocational training for general practice in inner London. Is there a dearth? And if so what's to be done?T Harris, T Silver, E Rink, et al.
American Family Physician|January 1, 1975
Diagnosis of plasma cell myelomaM W Pasmantier, M Coleman, R T Silver
Expert Review of Hematology|November 12, 2019
Myelofibrosis: best practices, controversies and 2019 updateNicole M Cruz, Usama Gergis, Richard T Silver
Pageof 24